Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04045379 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

LASER and Radiofrequency and Genitourinary Syndrome of Menopause

Study acronym: EPMLARF-arm1
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 22, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Aug 2024 to Aug 2025
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    v3
  2. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Primary completion date: Aug 2021 to Aug 2024
    • Study completion date: Aug 2023 to Aug 2025
    • Site contact updated
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized controlled trial to evaluate the use of LASER, Micro Ablative radiofrequency and topic strogen to treat symptoms of vulvovaginal atrophy of post menopause.
Trial Details
NCT Number NCT04045379
Lead Sponsor Federal University of São Paulo
Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions
(from sponsor)		 Postmenopausal Atrophic Vaginitis, Postmenopausal Symptoms, Genitourinary Symptoms
Related terms Atrophic Vaginitis
Enrollment 195 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov